earnings
confidence high
sentiment positive
materiality 0.85
Enovis Q3 sales up 9% to $549M; raises FY adjusted EBITDA and EPS guidance
Enovis CORP
2025-Q3 EPS reported
-$11.64
revenue$1,672,291,000
- Q3 net sales $549M (+9% reported, +7% organic); Recon +12% reported, P&R +6% reported.
- Net loss $571M including $548M non-cash goodwill impairment; adjusted EPS $0.75.
- Divested Dr. Comfort (Diabetic Footcare) unit in Oct for up to $60M.
- Raised FY2025 guidance: revenue $2.24-2.27B, adj. EBITDA $395-405M, adj. EPS $3.10-3.25.